Please login to the form below

Not currently logged in
Email:
Password:

Precision BioSciences

This page shows the latest Precision BioSciences news and features for those working in and with pharma, biotech and healthcare.

Gilead targets hep B in half a billion dollar deal with Precision BioSciences

Gilead targets hep B in half a billion dollar deal with Precision BioSciences

Inking a collaboration deal that would be worth half a billion dollars with genome editing specialists Precision Biosciences, Gilead is aiming to develop a cure for HBV, which is proving more ... This collaboration however, will target the in vivo

Latest news

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    Acquisition. $463m. Precision BioSciences/. Gilead Sciences. ARCUS technology; targeting in vivo elimination of. ... Gilead has also agreed a strategic collaboration with Precision BioSciences worth $445m in potential milestones; in addition there are

  • Deal Watch February 2016 Deal Watch February 2016

    Baxalta entered the chimeric antigen receptor (CAR) T-cell therapy area through its multi-programme immuno-oncology alliance with genome editing company, Precision BioSciences. ... acquisition - company. 2, 775. Precision Biosciences/ Baxalta. allogeneic

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics